{
    "pmcid": "8677774",
    "qa_pairs": {
        "How do VNARs primarily maintain high specificity and affinity despite their smaller binding interfaces?": [
            "Hydrogen bonding and hydrophobic interactions",
            "Electrostatic interactions and covalent bonding",
            "Van der Waals forces and ionic interactions",
            "Disulfide bridges and pi stacking"
        ],
        "What is a suggested therapeutic application of VNARs according to the study?": [
            "Complementing existing vaccines and antibody therapies",
            "Replacing all current antiviral drugs",
            "Serving as a standalone vaccine",
            "Preventing all viral infections"
        ],
        "What is the primary function of the S1 subunit in the SARS-CoV-2 spike protein?": [
            "Receptor binding",
            "Membrane fusion",
            "Viral replication",
            "Immune evasion"
        ],
        "What potential advantage do VNARs have over conventional antibodies in terms of cross-reactivity?": [
            "Cross-reactivity with other coronaviruses, including SARS-CoV-1 and pre-emergent zoonotic viruses",
            "Higher affinity for the ACE2 receptor",
            "Ability to neutralize all known variants of SARS-CoV-2",
            "Complete resistance to viral mutations"
        ],
        "Which VNAR binds to an epitope on the RBD that is accessible only when the RBD is in the 'up' conformation?": [
            "VNAR-3B4",
            "VNAR-2C02",
            "VNAR-4C10",
            "VNAR-1A1"
        ]
    }
}